• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,3,3-三甲基-N-[(2-吡啶基)甲基]-2-氧杂双环[2.2.2]辛烷-6-胺的酰胺类化合物,具有镇静和抗心律失常活性。

Amides of 1,3,3-trimethyl-n-[(2-pyridyl)methyl]-2-oxabicyclo [2.2.2]octan-6-amine with depressant and antiarrhythmic activities.

作者信息

Mariani E, Bondavalli F, Schenone P, Benincasa T, Vitagliano S, Marmo E

机构信息

Istituto di Scienze Farmaceutiche, Università di Genova, Italy.

出版信息

Farmaco. 1989 May;44(5):503-10.

PMID:2789628
Abstract

The synthesis of 1,3,3-trimethyl-N-[(2-pyridyl)methyl]-2- oxabicyclo [2.2.2]octan-6-amine (II) (exo, endo mixture) starting from 1,3,3-trimethyl-N-nitro-2-oxabicyclo [2.2.2]octan-6-imine (I), as well as of a series of amides (III) derived from the above amine, is described. Some compounds (III) showed remarkable depressant and antiarrhythmic activities in rats and mice, respectively, whereas the clofibric acid amide (III e) showed an appreciable hypolipidemic activity in rats. Moreover, the above compounds usually exhibited a moderate infiltration anesthesia in mice, as well as a weak hypotensive and bradycardic activity in rats.

摘要

描述了从1,3,3-三甲基-N-硝基-2-氧杂双环[2.2.2]辛烷-6-亚胺(I)开始合成1,3,3-三甲基-N-[(2-吡啶基)甲基]-2-氧杂双环[2.2.2]辛烷-6-胺(II)(外消旋体、内消旋体混合物)以及一系列由上述胺衍生的酰胺(III)的过程。一些化合物(III)分别在大鼠和小鼠中表现出显著的镇静和抗心律失常活性,而氯贝酸酰胺(III e)在大鼠中表现出明显的降血脂活性。此外,上述化合物通常在小鼠中表现出中度浸润麻醉作用,在大鼠中表现出较弱的降压和心动过缓活性。

相似文献

1
Amides of 1,3,3-trimethyl-n-[(2-pyridyl)methyl]-2-oxabicyclo [2.2.2]octan-6-amine with depressant and antiarrhythmic activities.1,3,3-三甲基-N-[(2-吡啶基)甲基]-2-氧杂双环[2.2.2]辛烷-6-胺的酰胺类化合物,具有镇静和抗心律失常活性。
Farmaco. 1989 May;44(5):503-10.
2
1,3,3-Trimethyl-N-(2-pyridyl)-2-oxabicyclo[2.2.2]octan-6-amine derivatives with hypotensive and other activities.具有降压及其他活性的1,3,3-三甲基-N-(2-吡啶基)-2-氧杂双环[2.2.2]辛烷-6-胺衍生物
Farmaco Sci. 1986 Jun;41(6):454-63.
3
Aminoethers of 1,3,3-trimethyl-5-(phenylmethylene)-2-oxabicyclo[2.2.2]octan-6-h ydroxy imine with antiarrhythmic activity.具有抗心律失常活性的1,3,3-三甲基-5-(苯亚甲基)-2-氧杂双环[2.2.2]辛烷-6-羟基亚胺的氨基醚
Farmaco Sci. 1988 Nov;43(11):879-86.
4
Aminoethers of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]-octan-6-hydroxyimine with hypotensive activity. II.具有降压活性的(+)-1,3,3-三甲基-2-氧杂双环[2.2.2]辛烷-6-羟基亚胺的氨基醚。II.
Farmaco Sci. 1986 Aug;41(8):630-6.
5
Derivatives of 1,2,3,3-tetramethyl-2-azabicyclo [2.2.2]-octan-5-trans-ol with antiarrhythmic and other activities. VII.
Farmaco Sci. 1987 Jul;42(7):491-7.
6
Esters and N-substituted urethanes of 6-cis-dimethylamino-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-5-cis-ol with hypotensive and other activities.6-顺式-二甲基氨基-1,3,3-三甲基-2-氧杂双环[2.2.2]辛烷-5-顺式醇的酯类和N-取代脲类化合物,具有降压及其他活性。
Farmaco Sci. 1984 Jan;39(1):35-43. doi: 10.1002/chin.198425203.
7
N-Phenyl-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-cis-amine derivatives with hypotensive and other activities.具有降压及其他活性的N-苯基-1,3,3-三甲基-2-氧杂双环[2.2.2]辛烷-6-顺式胺衍生物
Farmaco Sci. 1982 Mar;37(3):159-70. doi: 10.1002/chin.198234198.
8
Aminoethers of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-hydroxyimine with hypotensive activity.具有降压活性的(+)-1,3,3-三甲基-2-氧杂双环[2.2.2]辛烷-6-羟基亚胺的氨基醚
Farmaco Sci. 1985 Mar;40(3):170-7. doi: 10.1002/chin.198532182.
9
Derivatives of 1,2,3,3-tetramethyl-2-azabicyclo[2.2.2]octan-5-trans-ol with antiarrhythmic and other activities. VIII.具有抗心律失常及其他活性的1,2,3,3-四甲基-2-氮杂双环[2.2.2]辛烷-5-反式醇的衍生物。VIII.
Farmaco Sci. 1987 Sep;42(9):691-6.
10
Derivatives of 5,7,7-trimethyl-6-oxa-3-azabicyclo[3.2.2.] nonane with antiarrhythmic, local anesthetic and hypotensive activities. III.
Farmaco Sci. 1982 Jan;37(1):36-47.

引用本文的文献

1
Camphor nitroimine: a key building block in unusual transformations and its applications in the synthesis of bioactive compounds.莰酮硝基亚胺:一种在不寻常转化中具有关键作用的结构单元及其在生物活性化合物合成中的应用。
Mol Divers. 2022 Dec;26(6):3463-3483. doi: 10.1007/s11030-021-10341-0. Epub 2022 Jan 4.